SCHEMBL13504236

SCHEMBL13504236

CC(C)C(=O)c1ccn(Cc2cccc(F)c2F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.36
P2RX7 Q99572 2/20 0.35
ALKBH1 Q13686 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4A O75164 1/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NTRK1 P04629 2/20 0.34
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3754049 0.78 GAA (0.33) RIPK1P2RX7ALKBH1GPR119NTRK1
SCHEMBL13504501 0.76 CACNA1H (0.41) ALDH1A1
SCHEMBL2661612 0.74 ALKBH1 (0.41) RIPK1P2RX7ALKBH1MEN1KMT2A
SCHEMBL3743369 0.71 AR (0.43) P2RX7CYP3A4CYP2D6MAPT
SCHEMBL27587624 0.68 AKR1B1 (0.38) KDM4EALDH1A1AKR1B1POLBGAA
SCHEMBL20090412 0.66 RIPK1 (0.44) RIPK1P2RX7GPR119CYP1A2ALDH1A1
SCHEMBL4677240 0.66 KDM4A (0.42) RIPK1MEN1KMT2AKDM4AKDM5A
SCHEMBL12780284 0.66 CES2 (0.61) MEN1KMT2AALDH1A1GAA
SCHEMBL9714289 0.65 CA5A (0.45) ALKBH1KDM4AKDM5AKDM4CKDM5B
SCHEMBL28008353 0.64 CYP11B1 (0.46) MEN1KMT2AKDM4EALDH1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299115-B2 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2012-10-30 US disclosed